Format

Send to

Choose Destination
Toxicol Pathol. 2015 Feb;43(2):209-20. doi: 10.1177/0192623314530532. Epub 2014 May 28.

Evaluation of the chronic toxicity and carcinogenicity of perfluorohexanoic acid (PFHxA) in Sprague-Dawley rats.

Author information

1
Department of Environmental Health, Indiana University, Bloomington, Indiana, USA jklauni@indiana.edu.
2
AGC Chemicals, Asahi Glass Com., Ltd., Ichihara-shi, Chiba, Japan.
3
Daikin Industries, Ltd. Chemicals Division EHS Department, Settsu, Osaka, Japan.
4
WIL Research, Ashland, Ohio, USA.
5
Department of Environmental Health, Indiana University, Bloomington, Indiana, USA.
6
Research Pathology Associates, LLC, Clemson, South Carolina, USA.

Abstract

Perfluorohexanoic acid (PFHxA), a 6-carbon perfluoroalkyl (C6; CAS # 307-24-4), has been proposed as a replacement for the commonly used 8-carbon perfluoroalkyls: perfluorooctanoic acid and perfluorooctane sulfonate. PFHxA is not currently a commercial product but rather the ultimate degradation product of C6 fluorotelomer used to make C6 fluorotelomer acrylate polymers. It can be expected that, to a greater or lesser extent, the environmental loading of PFHxA will increase, as C6 fluorotelomer acrylate treatments are used and waste is generated. This article reports on a chronic study (duration 104 weeks) that was performed to evaluate the possible toxicologic and carcinogenic effects of PFHxA in gavage (daily gavage, 7 days per week) treated male and female Sprague-Dawley (SD) rats. In the current study, dosage levels of 0, 2.5, 15, and 100 mg/kg/day of PFHxA (males) and 5, 30, and 200 mg/kg/day of PFHxA (females) were selected based on a previous subchronic investigation. No effects on body weights, food consumption, a functional observational battery, or motor activity were observed after exposure to PFHxA. While no difference in survival rates in males was seen, a dose-dependent decrease in survival in PFHxA-treated female rats was observed. Hematology and serum chemistry were unaffected by PFHxA. PFHxA-related histologic changes were noted in the kidneys of the 200-mg/kg/day group females. Finally, there was no evidence that PFHxA was tumorigenic in male or female SD rats at any of the dosage levels examined.

KEYWORDS:

fluorocompounds; perfluorohexanoic acid (PFHxA); rat chronic exposure

PMID:
25377447
DOI:
10.1177/0192623314530532
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center